Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea

Multiple myeloma (MM) is the third most common hematologic malignancy in Korea. Historically, the incidence of MM in Korea has been lower than that in Western populations, although there is growing evidence that the incidence of MM in Asian populations, including Korea, is increasing rapidly. Despit...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Blood Res
Glavni autori: Kim, Hyo Jung, Yoon, Sung-Soo, Eom, Hyeon Seok, Kim, Kihyun, Kim, Jin Seok, Lee, Je-Jung, Bang, Soo-Mee, Min, Chang-Ki, Park, Joon Seong, Lee, Jae-Hoon
Format: Artigo
Jezik:Inglês
Izdano: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Teme:
Review Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4377347/
https://ncbi.nlm.nih.gov/pubmed/25830125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2015.50.1.7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items